![Gary Pace](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Pace
Direktor/Vorstandsmitglied bei
CARDIFF ONCOLOGY, INC.
Vermögen: 3 Mio $ am 31.05.2026
Profil
Dr. Gary W.
Pace is an Independent Director at Cardiff Oncology, Inc., a Partner & Investment Committee Chair at Pacific Channel Ltd., an Executive Chairman at View Point Medical, Inc. and a Professor at The University of Queensland.
He is on the Board of Directors at Cardiff Oncology, Inc., Curtana Pharmaceuticals, Inc., Immunicom, Inc., NeuroMedix, Inc., Protiveris, Inc., Sacron Innovations Pty Ltd. and Upstream Medical Technologies Ltd. Dr. Pace was previously employed as an Independent Non-Executive Director by Invitrocue Ltd., an Independent Non-Executive Director by Simavita Ltd., an Independent Non-Executive Director by Antisense Therapeutics Ltd., a Chairman by Sova Pharmaceuticals, Inc., an Independent Director by Pacira Biosciences, Inc., an Independent Director by Transition Therapeutics, Inc., an Independent Non-Executive Director by QRxPharma Ltd., a Chairman & Chief Executive Officer by Waratah Pharmaceuticals, Inc., a President & Chief Executive Officer by RTP Pharma, Inc, an Independent Director by ResMed, Inc., a Founder by Transcend Therapeutics, Inc., a Senior Vice President-Research & Development by Clintec, and a Vice Chairman by Hunter Immunology Pty Ltd. He also served on the board at Engender Technologies Ltd., Footfalls & Heartbeats (UK) Ltd., Peplin, Inc., Peplin Ltd., Celsion Corp., AVACEN, Inc. and Breathe Easy Ltd. He received his undergraduate degree from The University of New South Wales and a doctorate degree from Massachusetts Institute of Technology.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.06.2026 | 1’356’376 ( 1.98% ) | 3 Mio $ | 31.05.2026 |
Aktive Positionen von Gary Pace
| Unternehmen | Position | Beginn |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Direktor/Vorstandsmitglied | 22.04.2020 |
Upstream Medical Technologies Ltd.
 Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Develops biomarker-based testing for diagnoses of heart disease and associated clinical complications | Direktor/Vorstandsmitglied | - |
Curtana Pharmaceuticals, Inc.
 Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing of therapies for the treatment of brain cancer | Direktor/Vorstandsmitglied | - |
View Point Medical, Inc.
 View Point Medical, Inc. Medical SpecialtiesHealth Technology Manufactures one mark detection imaging system and tissue markers | Vorsitzender | - |
Immunicom, Inc.
 Immunicom, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for immunotherapy | Direktor/Vorstandsmitglied | - |
Sacron Innovations Pty Ltd. | Direktor/Vorstandsmitglied | - |
Protiveris, Inc.
 Protiveris, Inc. Information Technology ServicesTechnology Services Provides an IT, software and business services | Direktor/Vorstandsmitglied | - |
NeuroMedix, Inc.
 NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direktor/Vorstandsmitglied | - |
The University of Queensland
 The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| ░░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ehemalige bekannte Positionen von Gary Pace
| Unternehmen | Position | Ende |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Gary Pace
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
79
Beziehungen ersten Grades
32
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 32 |
|---|---|
ResMed, Inc.
 ResMed, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and markets devices for evaluation and treatment of sleep disorders | Health Technology |
Imunon, Inc.
 Imunon, Inc. BiotechnologyHealth Technology Engages in the provision of oncology drug development services | Health Technology |
Transcend Therapeutics, Inc.
 Transcend Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Protiveris, Inc.
Protiveris, Inc. Information Technology ServicesTechnology Services Provides an IT, software and business services | Technology Services |
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical development company that manufactures novel therapeutics for CNS, metabolic diseases and androgen deficiency indications | Commercial Services |
Waratah Pharmaceuticals, Inc.
 Waratah Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops pharmaceutical products | Health Technology |
Percheron Therapeutics Ltd.
 Percheron Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes antisense pharmaceuticals | Health Technology |
Peplin Ltd.
 Peplin Ltd. Pharmaceuticals: OtherHealth Technology Develops human therapeutic products for the treatment of cancer | Health Technology |
NeuroMedix, Inc.
NeuroMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Guardian Medical Solutions Ltd.
 Guardian Medical Solutions Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceutical products for pain management and central nervous system disorders | Health Technology |
Peplin, Inc.
 Peplin, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Health Technology |
Invitrocue Ltd.
 Invitrocue Ltd. Medical/Nursing ServicesHealth Services Provides bio analytic solutions | Health Services |
Pacira Biosciences, Inc.
 Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
Clintec International, Inc. (Illinois)
 Clintec International, Inc. (Illinois) Pharmaceuticals: MajorHealth Technology Pharmaceuticals | Health Technology |
SkyePharma Canada, Inc.
 SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Improves the solubility of drugs via nano-particulate technology | Commercial Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
The University of New South Wales
 The University of New South Wales Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Queensland
The University of Queensland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hunter Immunology Pty Ltd.
 Hunter Immunology Pty Ltd. Medical SpecialtiesHealth Technology Develops immune modulators for treatment of respiratory diseases | Health Technology |
Sova Pharmaceuticals, Inc.
 Sova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery and development of human therapeutic drugs | Health Technology |
Breathe Easy Ltd.
 Breathe Easy Ltd. Medical/Nursing ServicesHealth Services Develops drug for cystic fibrosis | Health Services |
Pacific Channel Ltd.
 Pacific Channel Ltd. Investment ManagersFinance Pacific Channel invests in companies located in Australia, New Zealand, Singapore and in the United States. The firm targets companies operating in the field of deep technology, health, environment and ag/food sectors. It provides financing for pre-seed and early stage capital requirements with an investment size of USD 5 - 10 million. | Finance |
Sacron Innovations Pty Ltd. | |
Simavita Ltd.
 Simavita Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops and markets wearable & disposable sensors for the health care industry | Electronic Technology |
Footfalls & Heartbeats (UK) Ltd.
 Footfalls & Heartbeats (UK) Ltd. TextilesProcess Industries Designs, develops, and manufactures smart textiles | Process Industries |
AVACEN, Inc.
 AVACEN, Inc. Medical SpecialtiesHealth Technology Develops pain relief medical devices | Health Technology |
Engender Technologies Ltd.
 Engender Technologies Ltd. Medical/Nursing ServicesHealth Services Develops proprietary process to separate bearing bull sperm cells | Health Services |
Upstream Medical Technologies Ltd.
Upstream Medical Technologies Ltd. BiotechnologyHealth Technology Develops biomarker-based testing for diagnoses of heart disease and associated clinical complications | Health Technology |
View Point Medical, Inc.
View Point Medical, Inc. Medical SpecialtiesHealth Technology Manufactures one mark detection imaging system and tissue markers | Health Technology |
Immunicom, Inc.
Immunicom, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for immunotherapy | Health Technology |
Curtana Pharmaceuticals, Inc.
Curtana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing of therapies for the treatment of brain cancer | Health Technology |
